Noom Med tirzepatide review
Advertised at $149 and billed at $149 — no gap. Position 0 of 18 on our board.
Updated 2026-09-18
DISCLOSURE — Coreage Rx pays this desk a commission when a reader signs up through our link. It buys no ranking, no score and no deletions. Method: how we rate. Full terms: disclosure.
Noom Med from $149 a month, and a separate microdose programme from $79 with medication included. Those two numbers describe different treatments.
Microdosing means deliberately low doses, below the levels used in the trials that produced the weight-loss figures people have read. That is a legitimate clinical approach and a poor basis for a price comparison.
The numbers
| Noom Med · tirzepatide | |
|---|---|
| Advertised | $149/mo |
| Membership | None |
| Billed | $149/mo |
| Advertised-to-billed gap | None |
| Per year | $1,788 |
| Board position | 0 of 18, cheapest first |
Availability by dose varies; the microdose programme is not full-dose therapy.
Where the gap is
No fee gap. The gap is dose. A $79 microdose programme sitting beside a $99 full-dose programme in a price table is comparing two different things, and the table will not tell you.
Against the board
About $1,788 a year for the standard programme, roughly $948 for microdose. The coaching is the best on the board by a distance.
| Programme | Advertised | Billed | Gap | Vs board floor |
|---|---|---|---|---|
| Coreage Rx | $149 | $199 | +$50 | +$74/mo |
| Trimi | $125 | $125 | none | — |
| Ozari Health | $125 | $125 | none | — |
| Fifty 410 | $133 | $133 | none | +$8/mo |
| PlexusDx | $129 | $189 | +$60 | +$64/mo |
| Ivím Health | $199 | $199 | none | +$74/mo |
| Zealthy | $216 | $216 | none | +$91/mo |
| Hims & Hers | $199 | $238 | +$39 | +$113/mo |
How the programme works
Behaviour-change app with a clinical arm. Sells a conventional GLP-1 programme and a lower-dose "microdose" programme with medication included.
Verified facts
- Noom Med listed from $149/month.
- Microdose GLP-1Rx programme listed from $79/month with medication included.
- Programme pairs low-dose medication with biomarker monitoring and coaching.
Checked 2026-09-18. This market re-prices without notice — anything older than a month is a starting point, not a quote.
For it
- The coaching is the actual product here and it is well built.
- Medication is included in the microdose tier rather than billed separately.
- Straightforward cancellation.
Against it
- Microdosing is not equivalent to the doses used in the trials people have read about.
- Full-dose therapy costs the same as competitors without the price advantage.
Read this bit. A $79 microdose programme is not the same treatment as 10 mg tirzepatide. Check the dose before comparing on price.
Score
3.5 out of 5 on our rubric, which is fixed before assessment and published on how we rate.
| Criterion | Weight | Score |
|---|---|---|
| True monthly cost | 30% | 3.6 / 5 |
| Price honesty | 20% | 3.2 / 5 |
| Clinical support | 20% | 3.8 / 5 |
| Pharmacy sourcing | 15% | 3.3 / 5 |
| Cancelling | 15% | 3.6 / 5 |
Verdict
Buy it for the behavioural programme, which is genuinely the strongest here. Establish the dose before you set the price against anything else.
More from the desk
- Coreage Rx tirzepatide review
Advertised at $149, billed at $199. Position 1 of 18 on our board.
- Trimi tirzepatide review
Advertised at $125 and billed at $125 — no gap. Position 2 of 18 on our board.
- Ozari Health tirzepatide review
Advertised at $125 and billed at $125 — no gap. Position 3 of 18 on our board.
- Cheapest right now
Every programme sorted on what it bills, not what it advertises. Floor: $199/mo tirzepatide, $149/mo semaglutide.
- Six fee traps
Every advertised-to-billed gap on our board comes from one of these six structures. Learn them and you can read any of these sites in ninety seconds.
- Where the traps are
The biggest advertised-to-billed gaps on our board, and the programmes charging most for the same category of medication.